Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
[Hypertensive nephrosclerosis].
Krummel T, Bazin D, Faller AL, Hannedouche T.
Presse Med. 2012 Feb;41(2):116-24. doi: 10.1016/j.lpm.2011.04.008. Epub 2011 Jun 8.
Nephrosclerosis and hypertension.
Ono H, Ono Y.
Med Clin North Am. 1997 Nov;81(6):1273-88. doi: 10.1016/s0025-7125(05)70582-4.
Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis.
Sumida K, Hoshino J, Ueno T, Mise K, Hayami N, Suwabe T, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Fujii T, Ohashi K, Takaichi K, Ubara Y.
PLoS One. 2016 Jan 25;11(1):e0147690. doi: 10.1371/journal.pone.0147690. eCollection 2016.
Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis.
Amano H, Koike K, Haruhara K, Tsuboi N, Ogura M, Yokoo T.
Clin Exp Nephrol. 2020 Aug;24(8):688-695. doi: 10.1007/s10157-020-01885-w. Epub 2020 Apr 9.
A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy.
Kimura T, Washida N, Ohtsuki S, Sugita K, Hosoya K, Uchiyama K.
Clin Exp Nephrol. 2024 Jun;28(6):539-546. doi: 10.1007/s10157-024-02461-2. Epub 2024 Feb 25.
Renal vasculature in essential hypertension: a review of some contrarian evidence.
Tracy RE.
Contrib Nephrol. 2011;169:327-336. doi: 10.1159/000314908. Epub 2011 Jan 20.
Malignant or accelerated hypertension.
Vaziri ND.
West J Med. 1984 Apr;140(4):575-82.
"Benign" hypertensive nephrosclerosis.
Dasgupta I, Porter C, Innes A, Burden R.
QJM. 2007 Feb;100(2):113-9. doi: 10.1093/qjmed/hcl139. Epub 2007 Jan 23.
Progression of renal failure -- the role of hypertension.
Whitworth JA.
Ann Acad Med Singap. 2005 Jan;34(1):8-15.
